Sources

  1. Rinastiti M, et al. Int J Oral Maxillofac Surg. 2006; 35:247-251.
  2. Jin CZ, et al. Tissue Eng. 2007; 13:693-702.
  3. Niknejad H, et al. Eur Cell Mater. 2008; 15:88-99.
  4. He H, et al. J Biol Chem. 2009; 284:20136-20146.
  5. Data on file, Bio-Tissue, Inc., 2012.
  6. http://www.iovs.org/content/46/11/4079.full.pdf.
  7. Sambursky R, O'Brien TP. MMP-9 and the perioperative management of LASIK surgery. Curr Opin Ophthalmol. 2011 Jul; 22(4):294-303.
  8. Tighe et al, Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil to Kill Demodex Mites, Transl Vis Sci Technol, 2013,2(7):2.
  9. Hart et al, Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil) suppresses inflammatory mediator production by activated human monocytes, Inflammation Research, 2000; 49: 619-626.
  10. Liu et al, Pathogenic role of Demodex mites in blepharitis, Curr Opin Allergy Clin Immunol, 2012; 10: 505-510.
  11. Gao et al, Clinical treatment of ocular demodecosis by lid scrub with tea tree oil, Cornea, 2007; 26(2):136-43.
  12. Cox 2001 Interactions between components of the essential oil of Melaleuca alternifolia, Journal of Applied Microbiology, 2001; 91:492-497.
  13. Liang et al, High prevalence of demodex brevis infestation in chalazia, Am J Ophthalmol, 2014; 157(2):342-348.
  14. Huang et al, Ocular Demodicosis as a Risk Factor of Pterygium Recurrence, Ophthalmology, 2013; 120:1341-7
  15. Carson et al, Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties, Clinical Microbiology Reviews, 2006; 19(1):50-62.
  16. May et al, Time-kill Studies of tea tree oils on clinical isolates, J Antimicrob Chemother, 2000; 45: 639-643.